Regeneron Pharmaceuticals Ratios (2009-2026) | REGN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	97.00%	93.08%	106.00%	-314.60%	94.78%	93.99%	-178.00%	93.41%	93.27%	93.32%	92.47%	93.85%	93.73%	92.95%	88.32%	93.44%	92.50%	92.52%	96.45%	91.79%
EBT Margin (Quarter)	73.03%	52.61%	50.56%	2,122.20%	33.71%	51.42%	1,324.70%	27.13%	34.29%	33.03%	33.42%	22.28%	45.90%	40.13%	25.29%	29.88%	41.32%	46.97%	26.87%	23.05%
EBIT Margin (Quarter)	65.14%	53.50%	53.31%	2,517.00%	38.85%	41.68%	1,146.80%	29.94%	32.19%	33.04%	28.33%	23.89%	30.15%	31.70%	26.13%	19.54%	29.37%	27.35%	22.65%	17.83%
EBITDA Margin (Quarter)	65.14%	53.50%	53.31%	2,517.00%	38.85%	41.68%	1,146.80%	29.94%	32.19%	33.04%	28.33%	23.89%	30.15%	31.70%	26.13%	19.54%	29.37%	27.35%	22.65%	17.83%
Operating Margin (Quarter)	65.14%	53.50%	53.31%	2,517.00%	38.85%	41.68%	1,146.80%	29.94%	32.19%	33.04%	28.33%	23.89%	30.15%	31.70%	26.13%	19.54%	29.37%	27.35%	22.65%	17.83%
Net Margin (Quarter)	60.31%	47.27%	45.01%	1,947.00%	29.82%	44.81%	1,197.10%	25.86%	30.66%	29.97%	33.77%	22.96%	40.38%	36.03%	24.22%	26.70%	37.86%	38.89%	21.74%	20.17%
FCF Margin (Quarter)	8.52%	95.01%	44.78%	3,919.80%	14.38%	16.57%	1,567.70%	37.61%	35.63%	21.49%	24.41%	43.83%	9.48%	23.83%	28.06%	26.94%	32.51%	30.57%	23.74%	23.53%
Efficiency
Inventory Average (Quarter)	2.07B	2.02B	2.00B	1.97B	2.10B	2.32B	2.41B	2.41B	2.47B	2.53B	2.57B	2.65B	2.79B	2.95B	3.05B	3.14B	3.20B	3.23B	3.23B	3.15B
Assets Average (Quarter)	19.63B	22.58B	24.55B	25.89B	26.78B	27.44B	28.45B	29.64B	30.36B	31.41B	32.62B	33.72B	35.23B	36.76B	37.60B	37.65B	37.88B	39.19B	40.36B	40.71B
Invested Capital (Quarter)			0.72B	0.72B	0.72B	0.72B	0.72B				0.72B				0.72B				0.72B
Asset Utilization Ratio (Quarter)	0.63	0.60	0.65	0.52	0.42	0.39	0.21	0.31	0.31	0.31	0.40	0.39	0.38	0.38	0.38	0.37	0.38	0.36	0.36	0.37
Leverage & Solvency
Interest Coverage Ratio (Quarter)	232.44	130.08	187.21	5.82	3.93	3.53	65.91	3.94	4.05	4.96	52.88	7.18	11.66	45.37	21.76	33.43	105.83	53.20	13.73	22.72
Debt Ratio (Quarter)	0.09	0.08	0.08	0.08	0.07	0.07	0.07	0.07	0.06	0.06	0.06	0.06	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Times Interest Earned (Quarter)	232.44	130.08	187.21	5.82	3.93	3.53	65.91	3.94	4.05	4.96	52.88	7.18	11.66	45.37	21.76	33.43	105.83	53.20	13.73	22.72
Dividends & Payouts
FCF Payout Ratio (Quarter)																0.11	0.08	0.08	0.10	0.12
Valuation
Enterprise Value (Quarter)	-3.91B	-5.79B	-5.69B	-7.05B	-7.57B	-7.02B	-7.74B	-8.96B	-8.93B	-9.91B	-10.84B	-10.52B	-9.81B	-9.80B	-9.01B	-8.35B	-7.47B	-8.44B	-8.61B	-8.75B
Return Ratios
Return on Sales (Quarter)	0.01%	0.00%	0.00%	0.19%	0.00%	0.00%	0.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	42.02%	39.62%	43.39%	39.73%	28.87%	25.37%	18.73%	16.68%	15.90%	15.18%	13.86%	12.78%	12.31%	12.00%	11.86%	11.24%	11.23%	10.61%	9.94%	10.19%
Return on Invested Capital (Quarter)	0.04%	0.09%	0.11%	0.07%	0.03%	0.02%	0.01%	0.02%	0.02%	0.04%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.04%	0.04%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Regeneron Pharmaceuticals Ratios (2009-2026) | REGN

Research Tools

Developers

Regeneron Pharmaceuticals Ratios (2009-2026) | REGN

Create an account

Sign In

Reset Password